2 completed, 1 active not recruiting, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Post Liver Transplant: new trials by email Literature Review of Post Liver Transplant trials Research Report on Post Liver Transplant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CM for Patients With ALD After Liver Transplant Contingency Management - Alcohol Use Disorder, Alcohol; Liver | Not applicable | Completed | Arpan A. Patel, MD | 10 | 2024-09-17 | 2026-10-20 |
| Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant Tenofovir Alafenamide 25 MG - HBV, POST LIVER TRANSPLANT | Phase 4 | Unknown | Fudan University | 150 | 2021-07-29 | 2021-09-30 |
| Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant EnvarsusXR, Tacrolimus - Post Liver Transplant | Phase 2 / Phase 3 | Active not recruiting | Albert Einstein Healthcare Network | 35 | 2017-12-13 | 2021-01-08 |
| Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant Sofosbuvir, RBV - Recurrent Chronic Hepatitis C Virus, Post Liver Transplant | Phase 2 | Completed | Gilead Sciences | 40 | 2012-11-01 | 2014-12-19 |
Alcoholism (1) · Hepatitis C, Chronic (1) · Liver Diseases, Alcoholic (1)
Digestive System Diseases (2) · Liver Diseases (2) · Alcohol-Induced Disorders (1) · Alcohol-Related Disorders (1) · Blood-Borne Infections (1) · Chemically-Induced Disorders (1) · Chronic Disease (1) · Communicable Diseases (1) · Disease Attributes (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis C (1) · Hepatitis, Chronic (1) · Hepatitis, Viral, Human (1) · Infections (1)
Immunosuppression Therapy (1) · Ribavirin (1) · Sofosbuvir (1) · Standard of Care (1) · Tacrolimus (1) · tenofovir alafenamide (1)
Albert Einstein Healthcare Network (1) · Arpan A. Patel, MD (1) · Fudan University (1) · Gilead Sciences (1)
United States (3) · China (1) · France (1) · Germany (1) · New Zealand (1) · Spain (1)
Arpan G Patel, MD (1) · Jian Zhou (1) · Jill M. Denning, MA (1) · Manisha Verma, MBBS, MPH (1)
UL1TR001881 (1)